← FDA DRUG APPROVALS

FDA ANDA · ANDA080677

MANNITOL

Sponsor: FRESENIUS KABI USA

APPLICATION
ANDA080677
TYPE
ANDA
ORIGINAL APPROVAL
1972-08-11
LATEST ACTION
1999-08-13
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

MANNITOL 25%Prescription
MANNITOL 12.5GM/50ML · INJECTABLE · INJECTION

Approval history

1999-08-13Manufacturing (CMC) · Supplement 30AP
1995-07-14Manufacturing (CMC) · Supplement 35AP
1994-12-06Manufacturing (CMC) · Supplement 31AP
1993-04-08Labeling · Supplement 34AP
1992-05-01Labeling · Supplement 33AP
1991-06-19Labeling · Supplement 32AP
1989-01-11Manufacturing (CMC) · Supplement 28AP
1989-01-11Manufacturing (CMC) · Supplement 29AP
1985-12-12Manufacturing (CMC) · Supplement 26AP
1985-10-18Manufacturing (CMC) · Supplement 25AP
1985-01-10Manufacturing (CMC) · Supplement 23AP
1983-09-20Manufacturing (CMC) · Supplement 22AP
1982-11-08Manufacturing (CMC) · Supplement 19AP
1982-11-01Manufacturing (CMC) · Supplement 20AP
1972-08-11OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →